Category: Pharmaceuticals

Pharmaceuticals

Latest

Intl' Pharmaceuticals

Latest

Enhertu Approved in the EU for Certain NSCLC Patients

AstraZeneca and Daiichi Sankyo’s Enhertu (trastuzumab deruxtecan) was approved in the EU as monotherapy for the treatment of adult patients with advanced non-small cell lung cancer (NSCLC) whose tumors have an activating HER2 (ERBB2) mutation and who require systemic therapy following platinum-based chemotherapy with or without immunotherapy.